{"disease":{"id":"thalassemia-beta","name":"thalassemia beta"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05799118","title":"Study of the Role of Genetic Modifiers in Hemoglobinopathies","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Cyprus Institute of Neurology and Genetics","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT06539169","title":"FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"xCures","has_results":false},{"nct_id":"NCT06831799","title":"ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT06153784","title":"Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":603,"lead_sponsor_name":"Children's Hospital Karachi","has_results":false},{"nct_id":"NCT05506358","title":"Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada","phase":"NA","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"University of British Columbia","has_results":true},{"nct_id":"NCT05132270","title":"Clinical Experience of Thalidomide in Thalassemic Patients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Children's Hospital Karachi","has_results":false},{"nct_id":"NCT06512298","title":"Plasticizer Exposure and Its Consequences on Health","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT07099196","title":"Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in UAE.","phase":"NA","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Mohammed Bin Rashid University of Medicine and Health Sciences","has_results":false},{"nct_id":"NCT03376893","title":"Epidemiology of Silent and Overt Strokes in Sickle Cell Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":102,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT03183375","title":"The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Dr.Saqib Hussain Ansari","has_results":false},{"nct_id":"NCT07509996","title":"Risk Factors Affecting Growth in Thalassemic Children at AUCH","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":85,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07288762","title":"Gonadal Function in Thalassemic Patient","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04691323","title":"The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT06980662","title":"The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ataturk University","has_results":false},{"nct_id":"NCT01571635","title":"Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":46,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT06298630","title":"Long-term Follow-up Study of BRL-101 for TDT","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Bioray Laboratories","has_results":false},{"nct_id":"NCT03763656","title":"Pharmacokinetics of Oral Hydroxyurea Solution","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Nova Laboratories Limited","has_results":true},{"nct_id":"NCT04675645","title":"Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT05736419","title":"A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03040765","title":"Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Hamad Medical Corporation","has_results":false},{"nct_id":"NCT05675436","title":"Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT06314529","title":"Long-term Follow-up Study of BHC001 for TDT","phase":"","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Bioray Laboratories","has_results":false},{"nct_id":"NCT06734520","title":"Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia","phase":"NA","overall_status":"RECRUITING","enrollment_count":3,"lead_sponsor_name":"Guangzhou Women and Children's Medical Center","has_results":false},{"nct_id":"NCT06041620","title":"Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells","phase":"NA","overall_status":"RECRUITING","enrollment_count":2,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04776850","title":"Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies","phase":"EARLY_PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":26},"guidelines":[],"source":"Drug Landscape verified database"}